Back to Agenda
Insights Regarding Implementation of the ASAP Process
Session Chair(s)
Greg Ball, PHD
Safety Data Scientist, ASAPprocess, United States
We will focus on insights regarding implementation of the ASAP process, how it has been beneficial to implement, and results from a survey across a targeted sample of forward-thinking pharma companies (big and small).
Learning Objective : Describe the steps to implement the ASAP process at a smaller company with limited resources; Identify specific effficiencies achieved when applying the ASAP process to platform products or product families with shared componentts; Recognize how the ASAP process has been beneficial to implement for various projects.
Speaker(s)
Advantages of Earlier Systematic and Strategic Safety Planning
Vice President, Head of Pharmacovigilance, Tourmaline Bio, United States
Insights Regarding Implementation of the ASAP Process
Clinical Associate, Pediatric Infectious Diseases, University of Chicago, United States
Practical Implementation of ASAP Concepts
Head, Safety Statistics, UCB Biosciences, United States
Practical Implementation of ASAP Concepts
Associate Safety Lead, UCB Biosciences, United States
Have an account?